Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates-Reference-Cited by-同舟云学术

Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates

Published:2023-02-02 Issue:2 Volume:64 Page:3
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Grover Anita¹²,Sankaranarayanan Sethu¹³,Mathur Vidhu¹⁴,Suri Poojan¹,Qiu Haiyan¹,Andrews-Zwilling Yaisa¹,Mease Kirsten⁵,Taylor Lori K.¹,Cahir-McFarland Ellen¹,Keswani Sanjay¹⁶,Yednock Ted¹

Affiliation:

1. Annexon Biosciences Inc., Brisbane, California, United States

2. ACELYRIN, Inc., Agoura Hills, California, United States

3. Escape Bio, South San Francisco, California, United States

4. Acelot Inc., Palo Alto, California, United States

5. ToxStrategies Inc., Durham, North Carolina, United States

6. Phoenix R&D Solutions Ltd, London, United Kingdom

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference37 articles.

1. The classical complement cascade mediates CNS synapse elimination;Stevens;Cell,2007

2. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner;Schafer;Neuron,2012

3. The complement system: an unexpected role in synaptic pruning during development and disease;Stephan;Annu Rev Neurosci,2012

4. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes;Stasi;Invest Ophthalmol Vis Sci,2006

5. Aberrant complement system activation in neurological disorders;Ziabska;Int J Mol Sci,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05

2. Complement regulation in the eye: implications for age-related macular degeneration;Journal of Clinical Investigation;2024-05-01

3. Complement in human disease: approved and up-and-coming therapeutics;The Lancet;2024-01

4. Geographic atrophy: pathophysiology and current therapeutic strategies;Frontiers in Ophthalmology;2023-12-05

5. Therapeutic targeting of the complement system in ocular disease;Drug Discovery Today;2023-11